Healthpoint Ibuprofen

Healthpoint Ibuprofen is an oral ibuprofen product marketed in the EU. It contains the non‑steroidal anti‑inflammatory drug ibuprofen, a widely used analgesic, antipyretic and anti‑inflammatory agent. The exact strength and dosage form follow typical tablet or capsule presentations, providing reversible COX‑1 and COX‑2 inhibition to reduce prostaglandin synthesis. It is available without a prescription in EU countries and is intended for management of moderate pain, fever, or inflammatory conditions.

Healthpoint Ibuprofen is commonly used for the symptomatic relief of several conditions.

- Relief of mild to moderate pain such as tension‑type headache, dental extraction pain, or musculoskeletal aches and strains. - Reduction of fever associated with common viral or bacterial infections, as well as fever secondary to inflammatory conditions. - Control of inflammation in chronic conditions such as osteoarthritis, rheumatoid arthritis, or acute soft‑tissue injuries like sprains and strains. - Management of postoperative discomfort following minor surgical procedures, including dental surgery and minor dermatologic excisions. - Alleviation of dysmenorrhea (menstrual cramps) when other non‑pharmacologic measures are insufficient for pain control.

The safety profile of Healthpoint Ibuprofen reflects the typical adverse reactions observed with ibuprofen and other non‑steroidal anti‑inflammatory drugs.

Common: - Upset stomach, including nausea or dyspepsia. - Mild headache or dizziness. - Transient increase in blood pressure. - Minor skin reactions such as rash or itching. - Heartburn or mild acid reflux. - Dry mouth or mild taste alteration. - Mild insomnia or sleep disturbances.

Serious: - Gastrointestinal bleeding, ulceration, or perforation. - Acute kidney injury or worsening of chronic renal disease. - Severe hypersensitivity reactions, including anaphylaxis or Stevens‑Johnson syndrome. - Increased risk of cardiovascular events such as heart attack or stroke, particularly with high doses or prolonged use. - Liver enzyme elevations, usually asymptomatic.

When considering Healthpoint Ibuprofen, several precautions should be reviewed to minimize risks and ensure appropriate use.

- Assess for a history of gastrointestinal ulcers, bleeding, or chronic gastritis before use. - Evaluate renal function, especially in patients with dehydration, heart failure, or existing kidney disease. - Use the lowest effective dose for the shortest duration needed to control symptoms. - Avoid use in individuals with known hypersensitivity to ibuprofen or other NSAIDs. - Caution is advised during pregnancy, particularly in the third trimester, and while breastfeeding. - Discuss with a healthcare professional before combining with anticoagulants, antihypertensives, or other NSAIDs.

Healthpoint Ibuprofen may interact with several medicines; understanding these interactions helps prevent adverse effects.

Avoid: - Concurrent use with other NSAIDs (e.g., naproxen, diclofenac) due to increased risk of gastrointestinal and renal toxicity. - Combination with anticoagulants (warfarin, direct oral anticoagulants) because of heightened bleeding risk. - Use with selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents, which may amplify bleeding tendencies.

Use with caution: - Co‑administration with antihypertensive agents (ACE inhibitors, diuretics) may reduce blood pressure control. - Concurrent use with lithium can increase lithium serum levels, requiring monitoring. - Taking with corticosteroids may raise the chance of gastrointestinal ulceration.